MDH2 Antibodies

Santa Cruz Biotechnology features a diverse variety of MDH2 monoclonal antibodies for investigating malate dehydrogenase 2 (MDH2) in various biological processes. MDH2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MDH2 is a key enzyme in the tricarboxylic acid (TCA) cycle, playing a crucial role in cellular respiration and energy production. The enzyme catalyzes the reversible conversion of malate to oxaloacetate, which is essential for maintaining metabolic homeostasis. Proper functioning of MDH2 is vital for various physiological processes, and its dysregulation has been implicated in several diseases, including cancer and metabolic disorders. Understanding MDH2's role in cellular metabolism can provide valuable insights into disease mechanisms and potential therapeutic strategies. Research utilizing MDH2 monoclonal antibodies has revealed significant connections between metabolic pathways and disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of MDH2's role in health and disease.